ASH19 - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1770476577016
Cache Key: cqdTagPageBySlug:ash19
fetchCache[cqdTagPageBySlug:ash19].expirationTime: falsey
fetchCache[cqdTagPageBySlug:ash19]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -121492
-- Key: cqdTagPageBySlug:metabolic-reprogramming, seconds remaining: -121492
-- Key: cqdPostsByTag:cqd-migrated-tag-21137,1,10, seconds remaining: -121365
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:ash19 - retrieving from Sanity
CCCache.dataFetchCount: 17
Cache cleanup seconds remaining: 30000

Tag: ASH19

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Treatment for Myelofibrosis-Associated Anemia on the Horizon